SCHEMBL3805259

SCHEMBL3805259

c1ccc2c3c([nH]c2c1)C(C1CCOCC1)NCC3

nearest known ligand 0.68

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 7/20 0.68
HTR2C P28335 7/20 0.68
HTR7 P34969 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C19 P33261 1/20 0.55
MAPKAPK2 P49137 1/20 0.51
GRIN2B Q13224 1/20 0.50
SSTR3 P32745 7/20 0.49
KCNH2 Q12809 5/20 0.49
CACNA1F O60840 1/20 0.49
CACNA1D Q01668 1/20 0.49
CACNA1S Q13698 1/20 0.49
CACNA1C Q13936 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20524868 0.90 HTR7 (0.61) HTR2AHTR2CHTR7CYP3A4CYP2D6
SCHEMBL23116631 0.87 HTR2A (0.62) HTR2AHTR2CHTR7CYP3A4CYP2D6
SCHEMBL30697780 0.79 HTR7 (0.52) HTR2AHTR2CHTR7CYP3A4CYP2D6
SCHEMBL5613534 0.78 HTR2A (0.46) HTR2AHTR2CSSTR3KCNH2CACNA1F
SCHEMBL4091350 0.77 BRD3 (0.57) HTR7CYP3A4CYP2D6CYP2C19SSTR3
SCHEMBL2269874 0.73 GRIN2B (0.60) HTR2AHTR2CHTR7CYP3A4CYP2D6
SCHEMBL17839824 0.72 HTR7 (0.65) HTR7CYP3A4CYP2D6CYP2C19MAPKAPK2
Tetrahydroharman SCHEMBL7018798 0.72 HTR7 (0.65) HTR7CYP3A4CYP2D6CYP2C19MAPKAPK2
Tetrahydroharman SCHEMBL21012020 0.72 HTR7 (0.65) HTR7CYP3A4CYP2D6CYP2C19MAPKAPK2
SCHEMBL968830 0.72 HTR7 (0.65) HTR2AHTR2CHTR7CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2178537-A1 BETA CARBOLINE DERIVATIVES AS ANTIDIABETIC COMPOUNDS Merck Sharp & Dohme Corp. (US) 2010-04-28 EP disclosed
WO-2009011836-A1 BETA CARBOLINE DERIVATIVES AS ANTIDIABETIC COMPOUNDS MERCK & CO., INC. (US) 2009-01-22 WO disclosed